SEC Form 4 · accession 0001209191-17-031715
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barbara White
Officer — Chief Medical Officer
Period of report
May 11, 2017
Accepted (ET)
May 12, 2017 · 10:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 11, 2017 | P | 2,435 | $6.121 | A | 168,735 | D |
Table II — derivative securities
No Table II lines on this filing.